Holen Sie sich die Stockscreener-App
317.74
0.11%
0.36
Handel nachbörslich:
318.34
0.60
+0.19%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen (AMGN) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025 - ts2.tech
Amgen’s New Study on Maridebart Cafraglutide: A Potential Game-Changer in Obesity Treatment? - TipRanks
Amgen’s New Phase 3 Trial: A Potential Game-Changer for Obstructive Sleep Apnea Treatment - TipRanks
Provident Investment Management Inc. Invests $1.29 Million in Amgen Inc. $AMGN - MarketBeat
Thrivent Financial for Lutherans Increases Position in Amgen Inc. $AMGN - MarketBeat
MASTERINVEST Kapitalanlage GmbH Invests $2.77 Million in Amgen Inc. $AMGN - MarketBeat
Neuberger Berman Group LLC Grows Position in Amgen Inc. $AMGN - MarketBeat
Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year - Yahoo Finance
Rexford Capital Inc. Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
China Universal Asset Management Co. Ltd. Has $16.87 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever. - The Motley Fool
Coppell Advisory Solutions LLC Has $1.36 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN)’s Valuation After FDA Approval of Uplizna for Generalized Myasthenia Gravis - simplywall.st
Treasurer of the State of North Carolina Boosts Stake in Amgen Inc. $AMGN - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Has $23.15 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Bellevue Group AG Sells 56,827 Shares of Amgen Inc. $AMGN - MarketBeat
Banque Transatlantique SA Sells 141,712 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen’s Uplizna Approved For Its Largest And Most Competitive Indication Yet - Citeline News & Insights
FDA Grants Orphan Status to Amgen's (AMGN) Blinatumomab for Leuk - GuruFocus
Amgen (AMGN) Receives Maintained Rating, Price Target Lowered to - GuruFocus
FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease - Yahoo Finance
FDA Approves Amgen's Drug For Rare Muscle Disorder - Benzinga
Amgen (AMGN) Gains FDA Nod for Expanded Use of Uplizna in Myasth - GuruFocus
Morgan Stanley Adjusts Amgen Price Target to $304 From $329, Maintains Equalweight Rating - marketscreener.com
Amgen wins FDA nod for Uplizna in myasthenia gravis (AMGN) - Seeking Alpha
Quantinno Capital Management LP Purchases 19,014 Shares of Amgen Inc. $AMGN - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Lowers Holdings in Amgen Inc. $AMGN - MarketBeat
Peapack Gladstone Financial Corp Has $30.82 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Sei Investments Co. - MarketBeat
Amgen Says FDA Approves Uplizna For Autoimmune Disorder Treatment - marketscreener.com
FDA approves Amgen’s UPLIZNA for generalized myasthenia gravis - Investing.com
FDA Approves Amgen's UPLIZNA for New Myasthenia Gravis Treatment - GuruFocus
FDA approves Amgen’s UPLIZNA for generalized myasthenia gravis By Investing.com - Investing.com Australia
Amgen (NASDAQ:AMGN) gets FDA OK for Uplizna as first CD19 B-cell therapy for gMG - Stock Titan
The Manufacturers Life Insurance Company Reduces Position in Amgen Inc. $AMGN - MarketBeat
NewEdge Advisors LLC Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Wells Fargo Maintains Amgen (AMGN) Equal-Weight Recommendation - Nasdaq
Amgen Inc. (NASDAQ:AMGN) Announces Quarterly Dividend of $2.52 - MarketBeat
Amgen describes new GTPase KRAS mutant inhibitors - BioWorld MedTech
Amgen: Improving Balance Sheet Is Bringing The Stock Close To Being A "Buy" (NASDAQ:AMGN) - Seeking Alpha
Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Intact Investment Management Inc. Sells 10,800 Shares of Amgen Inc. $AMGN - MarketBeat
Ossiam Sells 13,818 Shares of Amgen Inc. $AMGN - MarketBeat
Wells Fargo Adjusts Price Target on Amgen to $325 From $300, Maintains Equalweight Rating - marketscreener.com
HSBC Adjusts Price Target on Amgen to $425 From $381, Maintains Buy Rating - marketscreener.com
Amgen (AMGN) to Participate in Upcoming Virtual Meeting - GuruFocus
Amgen Announces Dividend for the First Quarter of 2026, Payable on March 6, 2026 - marketscreener.com
Amgen Raises Quarterly Dividend to $2.52 a Share From $2.38, Payable March 6 to Shareholders of Record as of Feb. 13 - marketscreener.com
Amgen declares $2.52 per share dividend for first quarter 2026 By Investing.com - Investing.com UK
AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND - PR Newswire
Key facts: Amgen invests $900M in Ohio; hosts Clinical Research Forum in UAE - TradingView
State Street Corp Increases Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by SVB Wealth LLC - MarketBeat
Who Owns Amgen? Top Shareholders and Recent Insider Trades - TIKR.com
Fayez Sarofim & Co Acquires 18,213 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Daiwa Securities Group Inc. - MarketBeat
Bank of Nova Scotia Has $29.83 Million Stake in Amgen Inc. $AMGN - MarketBeat
Axa S.A. Purchases 103,665 Shares of Amgen Inc. $AMGN - MarketBeat
Rep. David Taylor Sells Amgen Inc. (NASDAQ:AMGN) Stock - MarketBeat
Amgen Inc. $AMGN Shares Bought by L2 Asset Management LLC - MarketBeat
Gabelli Funds LLC Sells 3,150 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Position Boosted by Federated Hermes Inc. - MarketBeat
Amgen Inc.'s (NASDAQ:AMGN) Intrinsic Value Is Potentially 68% Above Its Share Price - Yahoo Finance
Amgen Inc. $AMGN Shares Bought by Cerity Partners LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by California Public Employees Retirement System - MarketBeat
Amgen (NASDAQ:AMGN) Cut to "Buy" at Wall Street Zen - MarketBeat
Has the Market Fully Priced In Amgen’s Rally After Pipeline and Regulatory Milestones? - simplywall.st
BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens - Finviz
Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - GlobeNewswire Inc.
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - sharewise.com
A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain - simplywall.st
Erste Group upgrades Amgen stock rating to Buy from Hold on obesity drug - Investing.com
Amgen (NASDAQ:AMGN) Rating Increased to Buy at Erste Group Bank - MarketBeat
Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen
Tema Etfs LLC Has $3.62 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
2.28%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):